EMEA approval News
Most Popular EMEA approval Story
Bristol exec hints of Onglyza launch strategy
Now that AstraZeneca and Bristol-Myers Squibb have the EMEA's nod on Onglyza, they're revving up to launch the new diabetes remedy. First target: Germany. Timing: By the end of this quarter. Now, the Read more...
Latest Headlines
- August 11, 2010
- July 9, 2009
- July 6, 2009
- July 1, 2009
- June 19, 2009
- May 15, 2009
- April 20, 2009
- February 13, 2009
- November 13, 2008
- October 24, 2008
- October 3, 2008
- May 14, 2008
- March 27, 2008
- January 28, 2008
- August 30, 2007
- August 24, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
